Cita APA

Hoover, J. L., Singley, C. M., Elefante, P., DeMarsh, P., Zalacain, M., & Rittenhouse, S. (2017). Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats. Antimicrob Agents Chemother.

Chicago Style Citation

Hoover, Jennifer L., Christine M. Singley, Philippa Elefante, Peter DeMarsh, Magdalena Zalacain, i Stephen Rittenhouse. "Reducing Antibacterial Development Risk for GSK1322322 By Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats." Antimicrob Agents Chemother 2017.

Cita MLA

Hoover, Jennifer L., et al. "Reducing Antibacterial Development Risk for GSK1322322 By Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats." Antimicrob Agents Chemother 2017.